Selected article for: "acute respiratory distress syndrome and admission day"
Author: Kumakawa, Yasuaki; Hirano, Yohei; Sueyoshi, Koichiro; Ishihara, Tadashi; Kondo, Yutaka; Kawasaki, Takaaki; Takeuchi, Yuji; Nakamura, Yuki; Ishikawa, Kouhei; Watanabe, Yusuke; Saito, Wataru; Matsuda, Shigeru; Nakazawa, Takeshi; Sasaki, Shinichi; Okamoto, Ken; Hiroshi, Tanaka
Title: Late i.v. steroid treatment for severe COVID‐19‐induced acute respiratory distress syndrome: a case report
  • Cord-id: xoyhcpdd
  • Document date: 2020_9_23
    • ID: xoyhcpdd
    Snippet: BACKGROUND: The efficacy of steroid treatment for coronavirus disease (COVID‐19) is unknown. CASE PRESENTATION: A 67‐year‐old man was transported to our hospital due to impaired consciousness and respiratory failure. After admission, tracheal aspirate of the patient was harvested, and it tested positive for severe acute respiratory syndrome coronavirus 2 nucleic acid. He required veno‐venous extracorporeal membrane oxygenation to sustain his oxygenation. However, his respiratory failure
    Document: BACKGROUND: The efficacy of steroid treatment for coronavirus disease (COVID‐19) is unknown. CASE PRESENTATION: A 67‐year‐old man was transported to our hospital due to impaired consciousness and respiratory failure. After admission, tracheal aspirate of the patient was harvested, and it tested positive for severe acute respiratory syndrome coronavirus 2 nucleic acid. He required veno‐venous extracorporeal membrane oxygenation to sustain his oxygenation. However, his respiratory failure did not improve for 20 days. On day 20 of admission, we started to use i.v. steroid therapy. On day 23, lung opacity on the chest X‐ray cleared and the patient’s oxygen saturation improved significantly. We successfully removed extracorporeal membrane oxygenation on day 27. CONCLUSION: Our case report encourages more future trials to evaluate the therapeutic use of i.v. steroid in severe COVID‐19‐induced acute respiratory distress syndrome.

    Search related documents:
    Co phrase search for related documents
    • acute ards respiratory distress syndrome and adjunctive steroid therapy: 1
    • acute ards respiratory distress syndrome and liver enzyme: 1, 2, 3, 4
    • acute ards respiratory distress syndrome and loss fatigue: 1
    • acute ards respiratory distress syndrome and lung field: 1, 2, 3
    • acute ards respiratory distress syndrome and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and lung right lobe: 1
    • acute ards respiratory distress syndrome and lung tissue: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and lung tissue inflammation: 1, 2, 3, 4, 5, 6
    • acute respiratory distress syndrome and adjunctive steroid: 1, 2
    • acute respiratory distress syndrome and adjunctive steroid therapy: 1, 2
    • acute respiratory distress syndrome and liver enzyme: 1, 2, 3, 4, 5, 6
    • acute respiratory distress syndrome and loss fatigue: 1, 2, 3, 4
    • acute respiratory distress syndrome and lung field: 1, 2, 3, 4, 5, 6, 7, 8
    • acute respiratory distress syndrome and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory distress syndrome and lung injury hyperinflammation: 1
    • acute respiratory distress syndrome and lung opacity: 1, 2, 3, 4
    • acute respiratory distress syndrome and lung right lobe: 1
    • acute respiratory distress syndrome and lung tissue: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory distress syndrome and lung tissue inflammation: 1, 2, 3, 4, 5, 6, 7, 8, 9